• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝叶斯茶碱预测的准确性和稳定性。

The accuracy and stability of Bayesian theophylline predictions.

作者信息

Chrystyn H, Ellis J W, Mulley B A, Peake M D

机构信息

School of Pharmacy, Bradford University, West Yorkshire, England.

出版信息

Ther Drug Monit. 1988;10(3):299-305. doi: 10.1097/00007691-198803000-00011.

DOI:10.1097/00007691-198803000-00011
PMID:3176107
Abstract

Pharmacokinetic parameters for theophylline were determined in 33 patients (3 women), mean age 61.2 years and weight 74.6 kg using the following three methods: (a) standard one-compartmental model calculations, assuming 100% bioavailability, after a single dose of theophylline syrup (mean dose 413 mg); (b) drug nomogram; and (c) Bayesian analysis. Patients entered a randomised study of three two-monthly dosage regimens using low, medium, and high theophylline twice daily doses. These doses produced mean (+/- SE) steady-state serum theophylline concentrations of 6.3 (+/- 0.4), 12.1 (+/- 0.3) and 18.3 (+/- 0.5) mg/L, respectively. A fourth period of placebo (2-month duration) was also included. At the end of each treatment period the measured serum theophylline concentration of each patient was compared with those predicted by each of the above three methods. The revised estimates derived from Bayesian analysis produced the least biased [mean prediction error (ME)] and most precise (mean squared prediction error) predictions for all three dosage periods. Statistical analysis of relative performance demonstrated that the difference in precision between the revised estimates and those of the other two methods was significant (p less than 0.05) with the magnitude of the difference increasing with dose. The revised estimates were also found to be less biased (p less than 0.05) than those of the nomogram. The ME (+/- SE) of the revised estimates for the low, medium, and high dosage periods was 0.34 (+/- 0.30), -0.02 (+/- 0.22) and -0.48 (+/- 0.31) mg/L, respectively.

摘要

采用以下三种方法测定了33例患者(3名女性)的茶碱药代动力学参数,患者平均年龄61.2岁,体重74.6kg:(a) 标准一室模型计算法,单剂量给予茶碱糖浆(平均剂量413mg)后,假设生物利用度为100%;(b) 药物剂量图表法;(c) 贝叶斯分析法。患者进入一项随机研究,该研究采用三种每两个月一次的给药方案,每日两次给予低、中、高剂量的茶碱。这些剂量分别产生平均(±标准误)稳态血清茶碱浓度为6.3(±0.4)、12.1(±0.3)和18.3(±0.5)mg/L。还包括一个为期2个月的安慰剂治疗期。在每个治疗期结束时,将每位患者测得的血清茶碱浓度与上述三种方法预测的浓度进行比较。贝叶斯分析得出的修正估计值在所有三个给药期的预测中偏差最小[平均预测误差(ME)]且最为精确(均方预测误差)。相对性能的统计分析表明,修正估计值与其他两种方法的精度差异显著(p<0.05),且差异幅度随剂量增加而增大。还发现修正估计值的偏差也小于剂量图表法(p<0.05)。低、中、高剂量期修正估计值的ME(±标准误)分别为0.34(±0.30)、-0.02(±0.22)和-0.48(±0.31)mg/L。

相似文献

1
The accuracy and stability of Bayesian theophylline predictions.贝叶斯茶碱预测的准确性和稳定性。
Ther Drug Monit. 1988;10(3):299-305. doi: 10.1097/00007691-198803000-00011.
2
Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.门诊条件下每日两次茶碱的贝叶斯推导预测及最佳采样时间评估。
Br J Clin Pharmacol. 1989 Feb;27(2):215-21. doi: 10.1111/j.1365-2125.1989.tb05353.x.
3
The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.使用每日一次给药的茶碱药代动力学预测指标的准确性。
Br J Clin Pharmacol. 1987 Sep;24(3):301-7. doi: 10.1111/j.1365-2125.1987.tb03173.x.
4
An evaluation of Bayesian microcomputer predictions of theophylline concentrations in newborn infants.新生儿茶碱浓度的贝叶斯微型计算机预测评估。
Ther Drug Monit. 1990 Jan;12(1):47-53. doi: 10.1097/00007691-199001000-00009.
5
Evaluation of a novel Bayesian method for individualizing theophylline dosage.一种用于个体化茶碱剂量的新型贝叶斯方法的评估。
J Clin Chem Clin Biochem. 1988 Jun;26(6):405-14. doi: 10.1515/cclm.1988.26.6.405.
6
Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.茶碱剂量个体化:一种在每日一次给药患者中评估的贝叶斯方法。
Ther Drug Monit. 1991 Sep;13(5):420-4.
7
A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosage.比较最小二乘回归法、贝叶斯法、邱氏法和稳态清除率法个体化茶碱剂量的准确性。
Clin Pharmacokinet. 1988 May;14(5):311-20. doi: 10.2165/00003088-198814050-00003.
8
Evaluation of three theophylline dosing methods in pediatric patients.评估三种小儿患者茶碱给药方法。
DICP. 1991 Feb;25(2):179-85. doi: 10.1177/106002809102500213.
9
Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.贝叶斯法、索丘克-扎斯克法及列线图给药法用于万古霉素的准确性。
Clin Pharm. 1987 Oct;6(10):795-9.
10
Disposition of intravenous theophylline in asthmatic children: Bayesian approach vs direct pharmacokinetic calculations.哮喘儿童静脉注射茶碱的处置:贝叶斯方法与直接药代动力学计算对比
Jpn J Pharmacol. 1997 Sep;75(1):13-20. doi: 10.1254/jjp.75.13.

引用本文的文献

1
Bayesian estimation of pharmacokinetic parameters: an important component to include in the teaching of clinical pharmacokinetics and therapeutic drug monitoring.药代动力学参数的贝叶斯估计:临床药代动力学教学和治疗药物监测中应纳入的重要组成部分。
Res Pharm Sci. 2020 Nov 27;15(6):503-514. doi: 10.4103/1735-5362.301335. eCollection 2020 Dec.
2
Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.低剂量口服茶碱作为吸入性糖皮质激素辅助药物预防慢性阻塞性肺疾病急性加重的应用:一项随机对照试验的研究方案
Trials. 2015 Jun 10;16:267. doi: 10.1186/s13063-015-0782-2.
3
Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.
门诊条件下每日两次茶碱的贝叶斯推导预测及最佳采样时间评估。
Br J Clin Pharmacol. 1989 Feb;27(2):215-21. doi: 10.1111/j.1365-2125.1989.tb05353.x.
4
Clinical pharmacokinetics 1990.临床药代动力学,1990年
Clin Pharmacokinet. 1990 Jan;18(1):1-19. doi: 10.2165/00003088-199018010-00001.
5
An updated comparison of drug dosing methods. Part II: Theophylline.药物给药方法的最新比较。第二部分:茶碱
Clin Pharmacokinet. 1991 Apr;20(4):280-92. doi: 10.2165/00003088-199120040-00003.
6
The prediction of steady-state plasma phenobarbitone concentrations (following low-dose phenobarbitone) to refine its use as an indicator of compliance.预测稳态血浆苯巴比妥浓度(低剂量苯巴比妥用药后),以优化其作为依从性指标的应用。
Br J Clin Pharmacol. 1991 Sep;32(3):329-33. doi: 10.1111/j.1365-2125.1991.tb03907.x.
7
Bayesian parameter estimation and population pharmacokinetics.
Clin Pharmacokinet. 1992 Jun;22(6):447-67. doi: 10.2165/00003088-199222060-00004.